FDA Adverse Event Malfunction Summary report: N

COBAS LITHIUM

MDR report key: 18933199 · Received March 19, 2024

Report

Report Number
1823260-2024-00811
Event Type
Malfunction
Date Received
March 19, 2024
Date of Event
February 21, 2024
Report Date
March 11, 2025
Manufacturer
ROCHE DIAGNOSTICS
Product Code
NDW
UDI-DI
07613336121382
PMA / PMN Number
K063684
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE FIELD SERVICE ENGINEER CHECKED THE ANALYZER AND DID NOT FIND A CAUSE. AS THE CUSTOMER WAS UNABLE TO PROVIDE FURTHER INFORMATION, A DEFINITE ROOT CAUSE ANALYSIS WAS NOT POSSIBLE. THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM. THE ISSUE WAS CONSISTENT WITH A PRE-ANALYTICAL HANDLING ISSUE AT THE CUSTOMER SITE. THE CUSTOMER WAS USING A SHORTER CENTRIFUGATION TIME THAN WHAT IS TYPICALLY RECOMMENDED BY TUBE MANUFACTURERS. CORRECT PRE-ANALYTIC SAMPLE HANDLING IS WITHIN THE CUSTOMER'S RESPONSIBILITY. THERE IS NO EVIDENCE TO SUGGEST A MALFUNCTION OF THE DEVICE.

Additional Manufacturer Narrative · 0

THE COBAS C 503 ANALYTICAL UNIT SERIAL NUMBER WAS (B)(6). THE INVESTIGATION IS ONGOING.

Additional Manufacturer Narrative · 0

MEDWATCH FIELDS A2, A3, A4, B7, AND D10 WERE UPDATED.

Description of Event or Problem · 0

THERE WAS AN ALLEGATION OF A QUESTIONABLE LITHIUM RESULT FROM THE COBAS C 503 ANALYTICAL UNIT. THE INITIAL RESULT WAS 0.1 MMOL/L WITH A DATA FLAG AND WAS REPORTED OUTSIDE OF THE LABORATORY. THE RESULT DID NOT MATCH THE PATIENT'S HISTORY AND THE SAMPLE WAS REPEATED. THE REPEAT RESULT WAS 2.3 MMOL/L AND WAS BELIEVED TO BE CORRECT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2276605 COBAS LITHIUM LITHIUM ASSAY NDW ROCHE DIAGNOSTICS ASKU 07613336121382

Patients

Seq Age Sex Outcome Treatment
1 54 YR Female ALPRAZOLAM (XANAX)| ESTRADIOL (ESTRACE)| QUETIAPINE FUMARATE (SEROQUEL)| SYNTHROID